跳至主要内容
临床试验/NCT04485780
NCT04485780Unknown4 期

The Optimal Timing of Botulinum Toxin Injection for Pain Control in Patients Undergoing Hemorrhoidectomy-A Prospective, Randomized Study

Tri-Service General Hospital1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2018年10月8日最近更新:
适应症

试验速览

阶段
4 期
入组人数
60
试验地点
1
主要终点
one week after operation

研究概览

简要总结

This is a prospective, randomized study, which anticipatedly recruited 60 patients in the outpatient department who need hemorrhoidectomy from January 2019 to December 2019. After obtaining those patients' consent in the clinic, they were randomly assigned to two groups at a 1:1 ratio using a computer-generated list of random numbers (Microsoft Excel). One group received Botulinum toxin injection during the outpatient clinic one week before the operation(experimental group, EG), and the other group received injection during the operation(control group, CG). The two groups were compared for the influence of postoperative pain control and wound healing rate.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients with age over 20 but under 80, who need to undergo hemorrhoidectomy

排除标准

  • patients under the age of 20
  • patients with nonsteroidal anti-inflammatory drugs (NSAIDs) allergy or sensitivity
  • patients with Botulinum toxin allergy or sensitivity
  • patients with dialysis or renal insufficiency
  • pregnant and breastfeeding women
  • vulnerable population

结局指标

主要结局

one week after operation

时间窗: 1 weel

The degree of postoperative pain is assessed by visual analog scale (VAS). After operation, we record patients' average VAS score and maximum VAS score every day until one week after surgery.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yi-Chiao Cheng

Attending surgeon, division of colon and rectal surgery

Tri-Service General Hospital

研究点 (1)

Loading locations...

相似试验